Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

bivalirudin MeSH Supplementary Concept Data 2025


MeSH Supplementary
bivalirudin
Unique ID
C074619
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C074619
Entry Term(s)
Angiomax
Angiomax RTU
BG 8967
BG-8967
BG8967
CTB-001
Hirulog
Hirulog-1
L-leucine, D-phenylalanyl-L-prolyl-L-arginyl-L-prolylglycylglycylglycylglycyl-L-asparaginylglycyl-L-alpha-aspartyl-L-phenylalanyl-L-alpha-glutamyl-L-alpha-glutamyl-L-isoleucyl-L-prolyl-L-alpha-glutamyl-L-alpha-glutamyl-L-tyrosyl-
Phe-Pro-Arg-Pro-(Gly)4 desulfato-Tyr63'-hirugen
Phe-Pro-Arg-Pro-(Gly)4-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu
Phe-Pro-Arg-Pro-(Gly)4-desulfohirudin-(53-64)
bivalirudin trifluoroacetate
Pharm Action
Antithrombins
Registry Numbers
TN9BEX005G
0
8631NP8608
Related Numbers
128270-60-0
8631NP8608
Previous Indexing
*RECOMBINANT PROTEINS (92)
Heading Mapped to
*Hirudins
*Peptide Fragments
Recombinant Proteins
Frequency
1297
Note
designed to bind to the alpha-thrombin catalytic site and anion-binding exosite for fibrin(ogen) recognition
Source
Biochem J 1992 May 1;283( Pt 3):737-43
Date of Entry
1992/06/18
Revision Date
2022/06/22
bivalirudin Preferred
BG 8967 Narrower
Hirulog Narrower
Angiomax Narrower
CTB-001 Narrower
bivalirudin trifluoroacetate Narrower
page delivered in 0.004s